Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C18H31N4O9.Gd |
| Molecular Weight | 604.71 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Gd+3].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1
InChI
InChIKey=ZPDFIIGFYAHNSK-CTHHTMFSSA-K
InChI=1S/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3/t14-,15-;/m1./s1
| Molecular Formula | C18H31N4O9 |
| Molecular Weight | 447.4601 |
| Charge | -3 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | Gd |
| Molecular Weight | 157.25 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:58:59 UTC 2023
by
admin
on
Fri Dec 15 16:58:59 UTC 2023
|
| Record UNII |
1BJ477IO2L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000183362
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
||
|
WHO-ATC |
V08CA09
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
||
|
WHO-VATC |
QV08CA09
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
||
|
NCI_THESAURUS |
C62358
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1BJ477IO2L
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
4179
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
84990
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | RxNorm | ||
|
68841
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
m5623
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | Merck Index | ||
|
C70675
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
SUB07861MIG
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
Gadobutrol
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
6102852
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
DTXSID101027434
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
138071-82-6
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
SUPERSEDED | |||
|
770691-21-9
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
CHEMBL2218860
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
C090600
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
1287449
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
GADOBUTROL
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
XX-91
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
DB06703
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
1BJ477IO2L
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
8231
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
100000092300
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY | |||
|
6882
Created by
admin on Fri Dec 15 16:58:59 UTC 2023 , Edited by admin on Fri Dec 15 16:58:59 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
EXCRETED UNCHANGED |
The urinary excretion of gadolinium was almost completed after 12 h post injection with a mean recovery between 90.4–99.3 % of the administered gadolinium dose.
URINE
|
||
|
SOLVATE->ANHYDROUS |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
a single intravenous administration of gadovist 1.0 M |
|
||